Teledermatology for COVID-19 cutaneous lesions: substitute or supplement?

Abstract

Journal of the European Academy of Dermatology and VenereologyVolume 34, Issue 10 p. e532-e533 Letter To The Editor Teledermatology for COVID-19 cutaneous lesions: substitute or supplement? C. Skayem, C. Skayem Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France Faculty of Medicine, Paris Diderot University, Paris, France Equal contributionSearch for more papers by this authorC. Cassius, C. Cassius Dermatology Department, AP-HP, Paris University, Saint-Louis Hospital, Paris, France INSERM U976 Human Immunology, Pathophysiology and Immunotherapy, Université de Paris, Paris, France Equal contributionSearch for more papers by this authorM. Ben Kahla, M. Ben Kahla Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, FranceSearch for more papers by this authorC. Fiani, C. Fiani Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, FranceSearch for more papers by this authorL. Frumholtz, L. Frumholtz Dermatology Department, AP-HP, Paris University, Saint-Louis Hospital, Paris, FranceSearch for more papers by this authorM. Mrad, M. Mrad Dermatology Department, AP-HP, Paris University, Saint-Louis Hospital, Paris, FranceSearch for more papers by this authorA. Petit, A. Petit Dermatology Department, AP-HP, Paris University, Saint-Louis Hospital, Paris, FranceSearch for more papers by this authorE. Zuelgaray, E. Zuelgaray Dermatology Department, AP-HP, Paris University, Saint-Louis Hospital, Paris, FranceSearch for more papers by this authorM. Bagot, M. Bagot Dermatology Department, AP-HP, Paris University, Saint-Louis Hospital, Paris, France INSERM U976 Human Immunology, Pathophysiology and Immunotherapy, Université de Paris, Paris, FranceSearch for more papers by this authorJ.D. Bouaziz, J.D. Bouaziz orcid.org/0000-0002-4993-2461 Dermatology Department, AP-HP, Paris University, Saint-Louis Hospital, Paris, France INSERM U976 Human Immunology, Pathophysiology and Immunotherapy, Université de Paris, Paris, France Equal contributionSearch for more papers by this authorT.A. Duong, Corresponding Author T.A. Duong tu-anh.duong@aphp.fr orcid.org/0000-0003-2221-9903 Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France Chaire Avenir Santé numérique, Equipe 8 IMRB U955, INSERM, Université Paris Est Créteil, Créteil, France Equal contribution Correspondence: T.A. Duong. E-mail: tu-anh.duong@aphp.frSearch for more papers by this author C. Skayem, C. Skayem Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France Faculty of Medicine, Paris Diderot University, Paris, France Equal contributionSearch for more papers by this authorC. Cassius, C. Cassius Dermatology Department, AP-HP, Paris University, Saint-Louis Hospital, Paris, France INSERM U976 Human Immunology, Pathophysiology and Immunotherapy, Université de Paris, Paris, France Equal contributionSearch for more papers by this authorM. Ben Kahla, M. Ben Kahla Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, FranceSearch for more papers by this authorC. Fiani, C. Fiani Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, FranceSearch for more papers by this authorL. Frumholtz, L. Frumholtz Dermatology Department, AP-HP, Paris University, Saint-Louis Hospital, Paris, FranceSearch for more papers by this authorM. Mrad, M. Mrad Dermatology Department, AP-HP, Paris University, Saint-Louis Hospital, Paris, FranceSearch for more papers by this authorA. Petit, A. Petit Dermatology Department, AP-HP, Paris University, Saint-Louis Hospital, Paris, FranceSearch for more papers by this authorE. Zuelgaray, E. Zuelgaray Dermatology Department, AP-HP, Paris University, Saint-Louis Hospital, Paris, FranceSearch for more papers by this authorM. Bagot, M. Bagot Dermatology Department, AP-HP, Paris University, Saint-Louis Hospital, Paris, France INSERM U976 Human Immunology, Pathophysiology and Immunotherapy, Université de Paris, Paris, FranceSearch for more papers by this authorJ.D. Bouaziz, J.D. Bouaziz orcid.org/0000-0002-4993-2461 Dermatology Department, AP-HP, Paris University, Saint-Louis Hospital, Paris, France INSERM U976 Human Immunology, Pathophysiology and Immunotherapy, Université de Paris, Paris, France Equal contributionSearch for more papers by this authorT.A. Duong, Corresponding Author T.A. Duong tu-anh.duong@aphp.fr orcid.org/0000-0003-2221-9903 Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France Chaire Avenir Santé numérique, Equipe 8 IMRB U955, INSERM, Université Paris Est Créteil, Créteil, France Equal contribution Correspondence: T.A. Duong. E-mail: tu-anh.duong@aphp.frSearch for more papers by this author First published: 18 May 2020 https://doi.org/10.1111/jdv.16630Citations: 20 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume34, Issue10October 2020Pages e532-e533 This article also appears in:JEADV COVID-19 articles RelatedInformation